1. Efficacy and Safety of Vildagliptin in New‐Onset Diabetes After Kidney Transplantation—A Randomized, Double‐Blind, Placebo‐Controlled Trial. Issue 1 (26th November 2013) Authors: Haidinger, M.; Werzowa, J.; Hecking, M.; Antlanger, M.; Stemer, G.; Pleiner, J.; Kopecky, C.; Kovarik, J. J.; Döller, D.; Pacini, G.; Säemann, M. D. Journal: American journal of transplantation Issue: Volume 14:Issue 1(2014:Jan.) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas–kidney transplantation with systemic venous insulin delivery. (11th May 2013) Authors: Stadler, M.; Krššák, M.; Jankovic, D.; Göbl, C.; Winhofer, Y.; Pacini, G.; Bischof, M.; Haidinger, M.; Saemann, M.; Mühlbacher, F.; Korbonits, M.; Baumgartner‐Parzer, S. M.; Luger, A.; Prager, R.; Anderwald, C.‐H.; Krebs, M. Journal: Clinical endocrinology Issue: Volume 80:Number 2(2014:Feb.) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Post‐transplantation diabetes mellitus: evaluation of treatment strategies. (May 2015) Authors: Haidinger, M.; Antlanger, M.; Kopecky, C.; Kovarik, J.J.; Säemann, M.D.; Werzowa, J. Journal: Clinical transplantation Issue: Volume 29:Number 5(2015) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗